IL-32γ plays a neuroprotective role after acute stroke in MCAO mouse model
Open Access
- 12 June 2025
- journal article
- Published by Scilight Press Pty Ltd in Journal of Inflammatory and Infectious Medicine
- Vol. 1 (2) , 3
Abstract
Stroke is believed to be the most common cause of permanent disability and is regarded as the second major cause of death. Within minutes of onset, cerebral ischemia triggers a cascade of pathophysiological events that ultimately result in irreversible tissue damage. Post-ischemic inflammation plays a critical role in cerebral ischemia-reperfusion injury, characterized by the elevated release of cytokines and chemokines. Interleukin (IL)-32 is known to induce several cytokines, particularly pro-inflammatory ones such as IL-6, tumor necrosis factor (TNF)α, and IL-1β. Targeting inflammatory pathways are of great interest in stroke research. In this study, we investigated the role of IL-32γ in a middle cerebral artery occlusion (MCAO) model using transgenic (TG) mice expressing human IL-32γ. Compared to wild-type (WT) mice, IL-32γ TG mice exhibited a significantly reduced infarct volume after MCAO. Accompanying the decreased brain tissue damage, the levels of pro-inflammatory cytokines IL-6, TNFα, and IL-1β were markedly lower in IL-32γ TG mice than in WT controls. These findings suggest that IL-32γ modulates the inflammatory response in ischemic brain injury. Specifically, IL-32γ reduced the expression of pro-inflammatory cytokines and the number of apoptotic cells following ischemic insult. In conclusion, our results demonstrate that IL-32γ regulates the neuroinflammatory response in brain injury and may serve as a potential neuroprotective therapeutic target.Keywords
This publication has 40 references indexed in Scilit:
- Molecular interactions and functions of IL-32Journal of Leukocyte Biology, 2020
- Inhibition of IL-32 Expression Ameliorates Cerebral Ischemia-Reperfusion Injury via the NOD/MAPK/NF-κB Signaling PathwayJournal of Molecular Neuroscience, 2020
- Knockdown of IL-32 protects PC12 cells against oxygen-glucose deprivation/reoxygenation-induced injury via activation of Nrf2/NF-κB pathwayMetabolic Brain Disease, 2020
- Identification of common key genes and pathways between type 1 diabetes and multiple sclerosis using transcriptome and interactome analysisEndocrine, 2020
- Immune Responses and Anti-inflammatory Strategies in a Clinically Relevant Model of Thromboembolic Ischemic Stroke with ReperfusionTranslational Stroke Research, 2019
- Microglia and Monocyte-Derived Macrophages in StrokeNeurotherapeutics, 2016
- Neuroinflammatory and Amyloidogenic Activities of IL-32β in Alzheimer’s DiseaseMolecular Neurobiology, 2014
- Reducing Effect of IL-32α in the Development of Stroke Through Blocking of NF-κB, but Enhancement of STAT3 PathwaysMolecular Neurobiology, 2014
- Role of Inflammation and Its Mediators in Acute Ischemic StrokeJournal of Cardiovascular Translational Research, 2013
- The effects of IL-32 on the inflammatory activation of cultured rat primary astrocytesBiochemical and Biophysical Research Communications, 2010